Gossamer Bio (GOSS) Invested Capital (2022 - 2025)
Historic Invested Capital for Gossamer Bio (GOSS) over the last 4 years, with Q3 2025 value amounting to -$82.3 million.
- Gossamer Bio's Invested Capital fell 13274.71% to -$82.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$82.3 million, marking a year-over-year decrease of 13274.71%. This contributed to the annual value of $227.0 million for FY2024, which is 1247.11% down from last year.
- Gossamer Bio's Invested Capital amounted to -$82.3 million in Q3 2025, which was down 13274.71% from -$46.1 million recorded in Q2 2025.
- Gossamer Bio's Invested Capital's 5-year high stood at $301.0 million during Q3 2023, with a 5-year trough of -$82.3 million in Q3 2025.
- In the last 4 years, Gossamer Bio's Invested Capital had a median value of $223.5 million in 2024 and averaged $171.4 million.
- As far as peak fluctuations go, Gossamer Bio's Invested Capital surged by 10891.83% in 2024, and later tumbled by 13274.71% in 2025.
- Over the past 4 years, Gossamer Bio's Invested Capital (Quarter) stood at $207.8 million in 2022, then grew by 24.82% to $259.4 million in 2023, then fell by 12.47% to $227.0 million in 2024, then plummeted by 136.27% to -$82.3 million in 2025.
- Its Invested Capital was -$82.3 million in Q3 2025, compared to -$46.1 million in Q2 2025 and -$6.2 million in Q1 2025.